Oncothyreon (ONTY), Array BioPharma (ARRY) Enter Collaboration Over ARRY-380
Tweet Send to a Friend
Oncothyreon Inc. (NASDAQ: ONTY) and Array BioPharma Inc. (Nasdaq: ARRY) announced that they will collaborate to develop and commercialize ARRY-380 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
